Giuseppe Currò

Prof. Giuseppe Currò


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GSGiuseppe Sammarco
Giuseppe Sammarco
Gilda VarricchiGilda Varricchi
Gilda Varricchi
VFVALENTINA FERRARO
VALENTINA FERRARO
MAMichele Ammendola
Michele Ammendola
MFMichele De Fazio
Michele De Fazio
Riccardo MemeoRiccardo Memeo
Riccardo Memeo
Gastric cancer is diagnosed in nearly one million new patients each year and it remains the second leading cause of cancer-related deaths worldwide. Although gastric cancer represents a heterogeneous group of diseases, chronic inflammation has been shown to play a role in tumorigenesis. Cancer development is a multistep process characterized by genetic and epigenetic alterations during tumour initiation and progression. The stromal microenvironment is important in maintaining normal tissue homeostasis or promoting tumour development. A plethora of immune cells (i.e., lymphocytes, macrophages, mast cells, monocytes, myeloid-derived suppressor cells, Treg cells, dendritic cells, neutrophils, eosinophils, natural killer (NK) and natural killer T (NKT) cells) are components of gastric cancer microenvironment. Mast cell density is increased in gastric cancer and there is a correlation with angiogenesis, the number of metastatic lymph nodes and the survival of these patients. Mast cells exert a protumorigenic role in gastric cancer through the release of angiogenic (VEGF-A, CXCL8, MMP-9) and lymphangiogenic factors (VEGF-C and VEGF-F). Gastric mast cells express the programmed death ligands (PD-L1 and PD-L2) which are relevant as immune checkpoints in cancer. Several clinical undergoing trials targeting immune checkpoints could be an innovative therapeutic strategy in gastric cancer. Elucidation of the role of subsets of mast cells in different human gastric cancers will demand studies of increasing complexity beyond those assessing merely mast cell density and microlocalization.

1 January 2007 in Annals of Surgery
Verified
Journal Article
Closed access
GCGiuseppe Currò
Giuseppe Currò
AMAnna Meo
Anna Meo
DIDaniela Ippolito
Daniela Ippolito
APAnna Pusiol
Anna Pusiol
ECEugenio Cucinotta
Eugenio Cucinotta
Our study aimed to evaluate the role of elective laparoscopic cholecystectomy (LC) in children with sickle cell disease (SCD) and asymptomatic cholelithiasis and, furthermore, to determine whether the outcome is related to the operation timing. The records of 30 children with SCD diagnosed with cholelithiasis from June 1995 to September 2005 were retraspectively reviewed. All 30 children were asymptomatic at the time of the first visit, and an elective LC was proposed to all of them. The operation was accepted in the period of study by 16 children and refused by 14. During medical observation, 10 of the 14 children who refused surgery were admitted for severe biliary colics. Acute cholecystitis was diagnosed by abdominal ultrasound in 3 cases and in 1 case choledocholithiasis, ultrasonographically suspected, was confirmed by magnetic resonance cholangiopancreatography (MRCP) and treated during endoscopic retrograde cholangiopancreatography (ERCP). All children, emergency admitted, underwent LC after the onset of symptoms. The patients were divided up into 2 groups (A: asymptomatic; B: symptomatic) depending on clinical presentation and operation timing and the respective outcomes were compared. Elective LC in asymptomatic children (group A) is safe with no major complications reported. During medical observation in children who refused elective surgery (group B), 6 biliary colics, 3 acute cholecystitis, and 1 choledocholithiasis were observed. Three sickle cell crises occurred in symptomatic children during biliary colics. The correlation between cholecystectomy performed in asymptomatic children (group A) and cholecystectomy performed in symptomatic children (group B) showed significant differences in the outcome. Morbidity rate and postoperative stay increased when children with SCD underwent emergency LC. Elective LC should be the gold standard in children with SCD and asymptomatic cholelithiasis to prevent the potential complications of biliary colics, acute cholecystitis, and choledocholithiasis, which lead to major risks, discomfort, and longer hospital stay.

19 April 2015 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
GCGiuseppe Currò
Giuseppe Currò
GMGiuseppe La Malfa
Giuseppe La Malfa
ACAntonio Caizzone
Antonio Caizzone
VRValentina Rampulla
Valentina Rampulla
GNGiuseppe Navarra
Giuseppe Navarra

30 October 2009 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
Umberto BaccaraniUmberto Baccarani
Umberto Baccarani
MIMiriam Isola
Miriam Isola
GAGian L. Adani
Gian L. Adani
CAClaudio Avellini
Claudio Avellini
DLDario Lorenzin
Dario Lorenzin
FBFabrizio Bresadola
Fabrizio Bresadola

18 June 2019 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
IKIman Komaei
Iman Komaei
FSFederica Sarra
Federica Sarra
CLClaudio Lazzara
Claudio Lazzara
MAMichele Ammendola
Michele Ammendola
RMRiccardo Memeo
Riccardo Memeo
GCGiuseppe Currò
Giuseppe Currò

1 May 2006 in Transplantation Proceedings
Verified
Journal Article
Closed access
Umberto BaccaraniUmberto Baccarani
Umberto Baccarani
GAG.L. Adani
G.L. Adani
DMD. Montanaro
D. Montanaro
ARA. Risaliti
A. Risaliti
DLD. Lorenzin
D. Lorenzin
FBF. Bresadola
F. Bresadola